Benjamin Puliafito, Matthew Lei, Andrew Yee, Diana Cirstea, Andrew Branagan, Emerentia Agyemang, Cynthia Harrington, Kacthary Sanclemente, Lisette Packer, Alexandra Wright, E. Bridget Kim, Brenna McCormick, Kareem Mosaheb, Julia Lin, Nora Horick, Eric Hua, Omar Nadeem, Matthew Frigault, Jacalyn Rosenblatt, Noopur Raje. "Deepening responses and MRD-conversion in a phase II fixed-duration consolidation trial of elranatamab post-idecabtagene vicleucel CAR-T cell therapy (EPIC) in relapsed or refractory multiple myeloma." Blood, 2025. doi:10.1182/blood-2025-5824